Insurance coverage significantly impacts patient access and out-of-pocket costs. Novo Nordisk's CEO stated that insured patients typically pay an average of $25 out-of-pocket monthly for these medications. However, many patients still struggle with affordability due to high premiums, deductibles, and co-payments.